ANI PHARMACEUTICALS, INC Depreciation
ANI PHARMACEUTICALS, INC (ANIP) reported Depreciation of $8.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-27
- ANI PHARMACEUTICALS, INC depreciation for the quarter ending 2020-12-31 was $1.30M, a 8.33% increase year-over-year.
- ANI PHARMACEUTICALS, INC depreciation for the quarter ending 2020-09-30 was $1.20M, a 9.09% increase year-over-year.
- ANI PHARMACEUTICALS, INC depreciation for the quarter ending 2020-06-30 was $1.20M, a 9.09% increase year-over-year.
- ANI PHARMACEUTICALS, INC depreciation for the quarter ending 2020-03-31 was $1.20M, a 0.00% change year-over-year.
- ANI PHARMACEUTICALS, INC depreciation for fiscal 2025 was $8.90M, a 20.27% increase from fiscal 2024.
- ANI PHARMACEUTICALS, INC depreciation for fiscal 2024 was $7.40M, a 1.33% decline from fiscal 2023.
- ANI PHARMACEUTICALS, INC depreciation for fiscal 2023 was $7.50M, a 1.35% increase from fiscal 2022.
- ANI PHARMACEUTICALS, INC depreciation for fiscal 2022 was $7.40M, a 34.55% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $8.90M 10-K · filed 2026-02-27 | |||||||
| 2024-12-31 | $7.40M 10-K · filed 2026-02-27 | |||||||
| 2023-12-31 | $7.50M 10-K · filed 2026-02-27 | |||||||
| 2022-12-31 | $7.40M 10-K · filed 2025-02-28 | |||||||
| 2021-12-31 | $5.50M 10-K · filed 2024-02-29 | |||||||
| 2020-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.50M derived: sum of 2 quarters · filed 2023-03-09 | $3.70M derived: sum of 3 quarters · filed 2023-03-09 | $4.80M 10-K · filed 2023-03-09 | ||||
| 2020-09-30 | $1.20M 10-Q · filed 2020-11-05 | $2.40M derived: sum of 2 quarters · filed 2020-11-05 | $3.50M 10-Q · filed 2020-11-05 | $4.80M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-06-30 | $1.20M 10-Q · filed 2020-08-06 | $2.30M 10-Q · filed 2020-08-06 | $3.60M derived: sum of 3 quarters · filed 2022-03-15 | $4.70M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-03-31 | $1.20M 10-Q · filed 2020-05-07 | $2.40M derived: sum of 2 quarters · filed 2022-03-15 | $3.50M derived: sum of 3 quarters · filed 2022-03-15 | $4.60M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.30M derived: sum of 2 quarters · filed 2022-03-15 | $3.40M derived: sum of 3 quarters · filed 2022-03-15 | $4.40M 10-K · filed 2022-03-15 | ||||
| 2019-09-30 | $1.10M 10-Q · filed 2020-11-05 | $2.20M derived: sum of 2 quarters · filed 2020-11-05 | $3.20M 10-Q · filed 2020-11-05 | $4.20M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-06-30 | $1.10M 10-Q · filed 2020-08-06 | $2.20M 10-Q · filed 2020-08-06 | $3.10M derived: sum of 3 quarters · filed 2021-03-11 | $3.70M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-03-31 | $1.20M 10-Q · filed 2020-05-07 | $1.10M 10-Q · filed 2019-05-09 | $2.00M derived: sum of 2 quarters · filed 2021-03-11 | $2.60M derived: sum of 3 quarters · filed 2021-03-11 | $3.00M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2018-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.40M derived: sum of 2 quarters · filed 2021-03-11 | $1.80M derived: sum of 3 quarters · filed 2021-03-11 | $2.10M 10-K · filed 2021-03-11 | ||||
| 2018-09-30 | $600.00K 10-Q · filed 2019-11-06 | $1.00M derived: sum of 2 quarters · filed 2019-11-06 | $1.30M 10-Q · filed 2019-11-06 | $1.60M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $400.00K 10-Q · filed 2019-08-07 | $700.00K 10-Q · filed 2019-08-07 | $1.00M derived: sum of 3 quarters · filed 2020-02-27 | $1.30M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $300.00K 10-Q · filed 2019-05-09 | $600.00K derived: sum of 2 quarters · filed 2020-02-27 | $900.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.20M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $600.00K derived: sum of 2 quarters · filed 2020-02-27 | $900.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.20M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $300.00K 10-Q · filed 2018-11-06 | $600.00K derived: sum of 2 quarters · filed 2018-11-06 | $900.00K 10-Q · filed 2018-11-06 | $1.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $300.00K 10-Q · filed 2017-08-03 | $600.00K 10-Q · filed 2018-08-07 | $800.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-08 | $500.00K derived: sum of 2 quarters · filed 2019-02-27 | $700.00K derived: sum of 3 quarters · filed 2019-02-27 | $900.00K derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $400.00K derived: sum of 2 quarters · filed 2019-02-27 | $600.00K derived: sum of 3 quarters · filed 2019-02-27 | $900.00K 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $200.00K 10-Q · filed 2017-11-02 | $400.00K derived: sum of 2 quarters · filed 2017-11-02 | $700.00K 10-Q · filed 2017-11-02 | $800.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $200.00K 10-Q · filed 2017-08-03 | $400.00K 10-Q · filed 2017-08-03 | $600.00K derived: sum of 3 quarters · filed 2018-02-27 | $800.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $200.00K 10-Q · filed 2017-05-04 | $400.00K derived: sum of 2 quarters · filed 2018-02-27 | $600.00K derived: sum of 3 quarters · filed 2018-02-27 | $800.00K derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $400.00K derived: sum of 2 quarters · filed 2018-02-27 | $600.00K derived: sum of 3 quarters · filed 2018-02-27 | $700.00K 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $200.00K 10-Q · filed 2016-11-03 | $400.00K derived: sum of 2 quarters · filed 2016-11-03 | $500.00K 10-Q · filed 2016-11-03 | $800.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | $200.00K 10-Q · filed 2016-08-04 | $300.00K 10-Q · filed 2016-08-04 | $600.00K derived: sum of 3 quarters · filed 2017-03-02 | $800.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | $200.00K 10-Q · filed 2016-05-05 | $400.00K derived: sum of 2 quarters · filed 2017-03-02 | $600.00K derived: sum of 3 quarters · filed 2017-03-02 | $700.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2014-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $400.00K derived: sum of 2 quarters · filed 2017-03-02 | $500.00K derived: sum of 3 quarters · filed 2017-03-02 | $600.00K 10-K · filed 2017-03-02 | $597.00K 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $200.00K 10-Q · filed 2015-11-03 | $153.00K 10-Q · filed 2014-11-10 | $300.00K derived: sum of 2 quarters · filed 2015-11-03 | $400.00K 10-Q · filed 2015-11-03 | $436.00K 10-Q · filed 2014-11-10 | $500.00K derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $100.00K 10-Q · filed 2015-08-04 | $146.00K 10-Q · filed 2014-08-07 | $300.00K 10-Q · filed 2015-08-04 | $283.00K 10-Q · filed 2014-08-07 | $300.00K derived: sum of 3 quarters · filed 2016-02-23 | $434.00K derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $100.00K 10-Q · filed 2015-05-05 | $137.00K 10-Q · filed 2014-05-12 | $200.00K derived: sum of 2 quarters · filed 2016-02-23 | $334.00K derived: sum of 3 quarters · filed 2016-02-23 | $468.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $234.00K derived: sum of 2 quarters · filed 2016-02-23 | $368.00K derived: sum of 3 quarters · filed 2016-02-23 | $500.00K 10-K · filed 2016-02-23 | $534.00K 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $134.00K 10-Q · filed 2014-11-10 | $133.97K 10-Q · filed 2013-11-07 | $268.00K derived: sum of 2 quarters · filed 2014-11-10 | $400.00K 10-Q · filed 2014-11-10 | $400.10K 10-Q · filed 2013-11-07 | $529.26K derived: sum of 4 quarters · filed 2014-11-10 | ||
| 2013-06-30 | $134.00K 10-Q · filed 2014-08-07 | $134.02K 10-Q · filed 2013-08-09 | $266.00K 10-Q · filed 2014-08-07 | $266.13K 10-Q · filed 2013-08-09 | $395.26K derived: sum of 3 quarters · filed 2014-08-07 | $526.72K derived: sum of 4 quarters · filed 2014-08-07 | ||
| 2013-03-31 | $132.00K 10-Q · filed 2014-05-12 | $261.26K derived: sum of 2 quarters · filed 2014-05-12 | $392.72K derived: sum of 3 quarters · filed 2014-05-12 | $520.86K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $129.26K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $260.72K derived: sum of 2 quarters · filed 2014-02-28 | $388.86K derived: sum of 3 quarters · filed 2014-02-28 | $517.00K 10-K · filed 2014-02-28 | ||||
| 2012-09-30 | $131.46K 10-Q · filed 2013-11-07 | $259.60K derived: sum of 2 quarters · filed 2013-11-07 | $387.74K 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $128.14K 10-Q · filed 2013-08-09 | $256.28K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |